Pricing | |||||
5400 | |||||
3400 | |||||
1800 | |||||
Study Period | 2019-2030 |
Market Size (2023): | 5.4Billion |
Market Size (2030): | 9.4Billion |
CAGR (2023 - 2030): | 8.20% |
Fastest Growing Region | North America |
Dominating Region | Europe |
Report Features |
Details |
Base Year |
2023 |
Based Year Market Size (2023) |
5.4Billion |
Historical Period |
2019 to 2023 |
CAGR (2023 to 2030) |
8.20% |
Forecast Period |
2023 to 2030 |
Forecasted Period Market Size (2030) |
9.4Billion |
Scope of the Report |
Segmentation by Type Chronic Disease Management, Nutritional Therapy, Oncology, Diabetes, Segmentation by Application Prescription Foods, Functional Foods, Nutritional Supplements, Medical Drinks, Therapeutic Foods, Sales Channel |
Regions Covered |
|
Companies Covered |
Nestlé Health Science, Danone, Abbott Laboratories, Perrigo, Medical Foods, Primus Pharmaceuticals, Nutricia, Otsuka Pharmaceutical, Nutra Pharma, Hopeway, Amedisys, Fresenius, Enlivant, Actavis |
Customization Scope |
15% Free Customization (For EG) |
Delivery Format |
PDF and Excel through Email |